State Street’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $167K | Hold |
21,600
| – | – | ﹤0.01% | 3880 |
|
|
2025
Q1 | $133K | Sell |
21,600
-300
| -1% | -$1.85K | ﹤0.01% | 3910 |
|
|
2024
Q4 | $107K | Hold |
21,900
| – | – | ﹤0.01% | 3973 |
|
|
2024
Q3 | $110K | Hold |
21,900
| – | – | ﹤0.01% | 3960 |
|
|
2024
Q2 | $90K | Buy |
21,900
+4,300
| +24% | +$17.7K | ﹤0.01% | 4035 |
|
|
2024
Q1 | $134K | Buy |
+17,600
| New | +$134K | ﹤0.01% | 3969 |
|
|
2023
Q2 | – | Sell |
-1,270
| Closed | -$7.37K | – | 4690 |
|
|
2023
Q1 | $7.37K | Hold |
1,270
| – | – | ﹤0.01% | 4757 |
|
|
2022
Q4 | $10.3K | Hold |
1,270
| – | – | ﹤0.01% | 4804 |
|
|
2022
Q3 | $12K | Sell |
1,270
-300
| -19% | -$2.84K | ﹤0.01% | 4882 |
|
|
2022
Q2 | $18K | Sell |
1,570
-18,979
| -92% | -$218K | ﹤0.01% | 4883 |
|
|
2022
Q1 | $436K | Sell |
20,549
-2,122
| -9% | -$45K | ﹤0.01% | 4110 |
|
|
2021
Q4 | $657K | Buy |
22,671
+6,684
| +42% | +$194K | ﹤0.01% | 3918 |
|
|
2021
Q3 | $1.56M | Buy |
15,987
+7,446
| +87% | +$728K | ﹤0.01% | 3679 |
|
|
2021
Q2 | $1.11M | Buy |
8,541
+3,840
| +82% | +$500K | ﹤0.01% | 3645 |
|
|
2021
Q1 | $849K | Buy |
+4,701
| New | +$849K | ﹤0.01% | 3658 |
|